Endogenex plans to use the funds to complete a pivotal trial of its endoscopic type 2 diabetes treatment and support a ...

Endogenex, a clinical-stage medical technology company pioneering a new treatment for type 2 diabetes (T2D), today announced the closing of a $50 million extension of its Series C financing. Arboretum ...

Endogenex designed its ReCET catheter for treating type 2 diabetes in the duodenum with a simple feature for speed and safety ...

Endogenex announced today that it has closed a $50 million extension of its Series C financing round to support its diabetes ...

MINNEAPOLIS, March 17, 2026 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving ...

Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes.

MINNEAPOLIS, May 03, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), presented significant ...

The mesentery is an organ that attaches all the digestive organs in the abdomen. It connects much of the intestines to the back abdominal wall, holding them in place when a person stands upright. The ...

Experiments using mouse models revealed that aging alters the balance of commensal (or helpful) microbes in the gut. These ...